Pages that link to "Q70606157"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics of probenecid following oral doses to human volunteers (Q70606157):
Displaying 26 items.
- Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G (Q24649515) (← links)
- Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy (Q27005614) (← links)
- The deterministic identifiability of nonlinear pharmacokinetic models (Q30011316) (← links)
- On the identification of Michaelis-Menten elimination parameters from a single dose-response curve (Q30011319) (← links)
- Pharmacokinetics and tolerability of oseltamivir combined with probenecid. (Q30370031) (← links)
- Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children (Q33883674) (← links)
- Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. (Q34596040) (← links)
- Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants (Q36022710) (← links)
- Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation (Q36024463) (← links)
- Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance. (Q37576154) (← links)
- Permeation thresholds for hydrophilic small biomolecules across microvascular and epithelial barriers are predictable on basis of conserved biophysical properties (Q42426412) (← links)
- Non-linear elimination and protein binding of probenecid (Q42660253) (← links)
- Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study (Q43739373) (← links)
- Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration (Q44477319) (← links)
- The use of probenecid as a chemoprotector against cisplatin nephrotoxicity (Q44795897) (← links)
- Probenecid Inhibits α-Adrenergic Receptor-Mediated Vasoconstriction in the Human Leg Vasculature. (Q45071370) (← links)
- Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib. (Q46119650) (← links)
- A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention (Q46577857) (← links)
- A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination (Q47786210) (← links)
- Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro. (Q50053955) (← links)
- Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans (Q68207621) (← links)
- Effect of probenecid on the elimination and protein binding of ceftriaxone (Q68411887) (← links)
- Sulfate homeostasis. IV. Probenecid-induced alterations of inorganic sulfate in rats (Q70193416) (← links)
- Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis (Q90076627) (← links)
- Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy (Q90696448) (← links)
- Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro (Q108581985) (← links)